BioCorRx Inc.
BICX
$0.34
$0.013.03%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 241.96% | -123.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 241.96% | -123.79% | |||
| Cost of Revenue | 107.48% | -193.92% | |||
| Gross Profit | 1.88% | -32.74% | |||
| SG&A Expenses | 43.77% | -52.91% | |||
| Depreciation & Amortization | 108.97% | -273.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 203.89% | -85.16% | |||
| Operating Income | -77.76% | 72.54% | |||
| Income Before Tax | -82.49% | 41.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -82.49% | 41.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -97.20% | 192.28% | |||
| Net Income | -250.42% | 128.81% | |||
| EBIT | -77.76% | 72.54% | |||
| EBITDA | -79.36% | 72.08% | |||
| EPS Basic | -236.55% | 122.54% | |||
| Normalized Basic EPS | -155.10% | 135.32% | |||
| EPS Diluted | -236.55% | 122.54% | |||
| Normalized Diluted EPS | -155.10% | 135.32% | |||
| Average Basic Shares Outstanding | 10.16% | 27.95% | |||
| Average Diluted Shares Outstanding | 10.16% | 27.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||